Activation of JNKs is essential for BMP9-induced osteogenic differentiation of mesenchymal stem cells

BMB Reports

Volumn 46, Issue 8, 2013, Pages 422-427

  Zhao, Yan fang ^a   Xu, Jing ^a   Wang, Wen juan ^a   Wang, Jin ^a   He, Juan wen ^a   Li, Li ^a   Dong, Qian ^a   Xiao, Yan ^a   Duan, Xing lian ^a   Yan, Xue ^a   Liang, Yi wen ^a   Song, Tao ^a   Tang, Min ^a   Zhao, Dan ^a   Luo, Jin yong ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

BMP9; Bone morphogenetic proteins; Mesenchymal stem cells; Mitogen activated protein kinases; Osteogenic differentiation

Indexed keywords

ANTHRA(1,9 CD)PYRAZOL 6(2H) ONE; ANTHRA(1,9-CD)PYRAZOL-6(2H)-ONE; ANTHRACENE DERIVATIVE; GROWTH DIFFERENTIATION FACTOR; SMAD PROTEIN; SMALL INTERFERING RNA; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL; ARTICLE; BONE DEVELOPMENT; CELL CULTURE; CELL DIFFERENTIATION; CELL STRAIN HCT116; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; MOUSE; PHOSPHORYLATION; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

ANIMALS; ANTHRACENES; CELL DIFFERENTIATION; CELLS, CULTURED; GROWTH DIFFERENTIATION FACTORS; HCT116 CELLS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MESENCHYMAL STROMAL CELLS; MICE; OSTEOGENESIS; PHOSPHORYLATION; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; SMAD PROTEINS;

EID: 84884567875     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2013.46.8.266     Document Type: Article

References (23)

1. Deng, Z. L., Sharff, K. A., Tang, N., Song, W. X., Luo, J., Luo, X., Chen, J., Bennett, E., Reid, R., Manning, D., Xue, A., Montag, A. G., Luu, H. H., Haydon, R. C. and He, T. C. (2008) Regulation of osteogenic differentiation during skeletal development. Front. Biosci. 13, 2001-2021.
2. Hogan, B. L. (1996) Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10, 1580-1594.
3. Chen, D., Zhao, M. and Mundy, G. R. (2004) Bone morphogenetic proteins. Growth Factors 22, 233-241.
4. Boraiah, S., Paul, O., Hawkes, D., Wickham, M. and Lorich, D. G. (2009) Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report. Clin. Orthop. Relat. Res. 467, 3257-3262.
5. Rutherford, R. B., Nussenbaum, B. and Krebsbach, P. H. (2003) Bone morphogenetic protein 7 ex vivo gene therapy. Drug. News Perspect. 16, 5-10.
6. Kang, Q., Sun, M. H., Cheng, H., Peng, Y., Montag, A. G., Deyrup, A. T., Jiang, W., Luu, H. H., Luo, J., Szatkowski, J. P., Vanichakarn, P., Park, J. Y., Li, Y., Haydon, R. C. and He, T. C. (2004) Characterization of the distinct orthotopic bone-forming activity of 14 BMPs using recombinant adenovirus- mediated gene delivery. Gene Ther. 11, 1312-1320.
7. Luu, H. H., Song, W. X., Luo, X., Manning, D., Luo, J., Deng, Z. L., Sharff, K. A., Montag, A. G., Haydon, R. C. and He, T. C. (2007) Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells. J. Orthop. Res. 25, 665-677.
8. Luo, J., Tang, M., Huang, J., He, B. C., Gao, J. L., Chen, L., Zuo, G. W., Zhang, W., Luo, Q., Shi, Q., Zhang, B. Q., Bi, Y., Luo, X., Jiang, W., Su, Y., Shen, J., Kim, S. H., Huang, E., Gao, Y., Zhou, J. Z., Yang, K., Luu, H. H., Pan, X., Haydon, R. C., Deng, Z. L. and He, T. C. (2010) TGFbeta/BMP type I receptors ALK1 and ALK2 are essential for BMP9-induced osteogenic signaling in mesenchymal stem cells. J. Biol. Chem. 285, 29588-29598.
9. Wu, N., Zhao, Y., Yin, Y., Zhang, Y. and Luo, J. (2010) Identification and analysis of type II TGF-{beta} receptors in BMP-9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells. Acta. Biochim. Biophys. Sin. (Shanghai). 42, 699-708.
10. Heldin, C. H., Miyazono, K. and ten Dijke, P. (1997) TGF-beta signaling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
11. Guicheux, J., Lemonnier, J., Ghayor, C., Suzuki, A., Palmer, G. and Caverzasio, J. (2003) Activation of p38 mitogen- activated protein kinase and c-Jun-NH2-terminal kinase by BMP-2 and their implication in the stimulation of osteoblastic cell differentiation. J. Bone Miner. Res. 18, 2060-2068.
12. Gallea, S., Lallemand, F., Atfi, A., Rawadi, G., Ramez, V., Spinella-Jaegle, S., Kawai, S., Faucheu, C., Huet, L., Baron, R. and Roman-Roman, S. (2001) Activation of mitogen-activated protein kinase cascades is involved in regulation of bone morphogenetic protein-2-induced osteoblast differentiation in pluripotent C2C12 cells. Bone 28, 491-498.
13. Liu, H., Liu, Y., Viggeswarapu, M., Zheng, Z., Titus, L. and Boden, S. D. (2011) Activation of c-Jun NH(2)-terminal kinase 1 increases cellular responsiveness to BMP-2 and decreases binding of inhibitory Smad6 to the type 1 BMP receptor. J. Bone Miner. Res. 26, 1122-1132.
14. Huang, Y. F., Lin, J. J., Lin, C. H., Su, Y. and Hung, S. C. (2012) c-Jun N-terminal kinase 1 negatively regulates osteoblastic differentiation induced by BMP2 via phosphorylation of Runx2 at Ser104. J. Bone Miner. Res. 27, 1093-1105.
15. Zhao, Y., Song, T., Wang, W., Wang, J., He, J., Wu, N., Tang, M., He, B. and Luo, J. (2012) P38 and ERK1/2 MAPKs act in opposition to regulate BMP9-induced osteogenic differentiation of mesenchymal progenitor cells. PLoS One 7, e43383.
16. Widmann, C., Gibson, S., Jarpe, M. B. and Johnson, G. L. (1999) Mitogen-activated protein kinase: conservation of a three-kinase module from yeast to human. Physiol. Rev. 79, 143-180.
17. Song, J. J., Celeste, A. J., Kong, F. M., Jirtle, R. L., Rosen, V. and Thies, R. S. (1995) Bone morphogeneticprotein-9 binds to liver cells and stimulates proliferation. Endocrinology 136, 4293-4297.
18. López-Coviella, I., Berse, B., Krauss, R., Thies, R. S. and Blusztajn, J. K. (2000) Induction and maintenance of the neuronal cholinergic phenotype in the central nervous system by BMP9. Science 289, 313-316.
19. Chen, C., Grzegorzewski, K. J., Baras, S., Zhao, Q., Schneider, H., Wang, Q., Singh, M., Pukac, L., Bell, A. C., Duan, R., Coleman, T., Duttaroy, A., Cheng, S., Hirsch, J., Zhang, L., Lazard, Y., Fischer, C., Barber, M. C., Ma, Z. D., Zhang, Y. Q., Reavey, P., Zhong, L., Teng, B., Sanyal, I., Ruben, S. M., Blondel, O. and Birse, C. E. (2003) An integrated functional genomics screening program reveals a role for BMP-9 in glucose homeostasis. Nat. Biotechnol. 21, 294-301.
20. Truksa, J., Peng, H., Lee, P. and Beutler, E. (2006) Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferring receptor 2 (Tfr2), and IL-6. Proc. Natl. Acad. Sci. U.S.A. 103, 10289-10291.
21. Li, C., Yang, X., He, Y., Ye, G., Li, X., Zhang, X., Zhou, L. and Deng, F. (2012) Bone morphogenetic protein-9 induces osteogenic differentiation of rat dental follicle stem cells in P38 and ERK1/2 MAPK dependent manner. Int. J. Med. Sci. 9, 862-871.
22. Tian, X. Y., Yung, L. H., Wong, W. T., Liu, J., Leung, F. P., Liu, L., Chen, Y., Kong, S. K., Kwan, K. M., Ng, S. M., Lai, P. B., Yung, L. M., Yao, X. and Huang, Y. (2012) Bone morphogenic protein-4 induces endothelial cell apoptosis through oxidative stress-dependent p38MAPK and JNK pathway. J. Mol. Cell Cardiol. 52, 237-244.
23. Sovershaev, M. A., Egorina, E. M., Sovershaev, T. A., Svensson, B. and Hansen, J. B. (2011) Increased expression of TF in BMP-7-treated human mononuclear cells depends on activation of select MAPK signaling pathways. Thromb. Res. 128, e154-159.